Bias in AI systems mainly comes from the data used to train these models, how they are created, and how they work in healthcare settings. According to research by the United States and Canadian Academy of Pathology, there are three types of biases: data bias, development bias, and interaction bias.
AI bias in healthcare can cause serious problems. W. Nicholson Price II, a researcher studying AI risks, points out that AI errors can affect many patients at once, unlike human mistakes that usually affect fewer people. For example, bias in AI can cause wrong treatment or diagnosis for some racial groups, making inequalities worse.
One example is how African-American patients often get less pain treatment than white patients. If AI systems learn from biased data, they may suggest lower doses of pain medicine for African-American patients, which makes the problem worse. This is especially concerning because AI systems may work quietly without patients or doctors noticing problems.
Also, voice recognition AI used in front offices or clinics may not work well for voices from underrepresented racial or gender groups. This makes automated tools less effective for these patients and can reduce access to care.
Healthcare data in the United States is often fragmented, which makes bias problems worse and makes AI development harder. Patients get care from many providers who may use different electronic health records (EHRs) and insurance plans. This creates incomplete or inconsistent data. AI systems trained on this partial data may miss important information or give wrong predictions, which can harm patients.
Privacy is also a concern because AI needs a lot of data to work well. Beyond the data collected directly, AI can guess sensitive information without being told explicitly. For example, some systems can detect diseases like Parkinson’s by noticing small behavior patterns. This can make patients worried about their private health information and open the door to misuse of their data by others.
The Food and Drug Administration (FDA) controls some AI products used in healthcare. But many AI systems made inside hospitals or by software developers are not regulated by the FDA. This gap in rules means some AI tools might not be checked well for safety and quality before being used.
Groups like the American College of Radiology and the American Medical Association could help close these regulatory gaps by making standards and best practices. But making AI safe and fair needs teamwork from health systems, software developers, regulators, and doctors.
Ethically, AI tools must be clear, fair, and responsible. Matthew G. Hanna and others say fairness is not just about the first design but also requires ongoing checks to find new biases as healthcare changes. Without this, AI may make healthcare inequalities worse and cause patients to trust the technology less.
Using AI fairly in healthcare needs several actions working together. Medical practice leaders in the United States play important roles in making sure AI serves all patients equally.
While AI often gets attention for use in diagnosis and clinical decisions, it also helps in healthcare administration. Simbo AI is a company that offers AI systems to automate front-office phone services. These solutions reduce staff workload and improve patient access.
In busy U.S. clinics, phone lines can get very busy, causing missed appointments and unhappy patients. AI answering systems respond quickly and correctly to patient calls. They can schedule, remind, and send calls to the right departments. This lets staff focus on harder tasks.
However, voice recognition AI in phone systems may not work well for some accents or speech patterns, especially from racial or ethnic minorities. This can make it harder for these groups to get care. To fix this, voice data from all groups must be collected and AI performance checked regularly for fairness.
AI automation can also help manage electronic health records (EHR) and appointment systems. This reduces stress for doctors and staff. Automating routine work lets clinics spend more time on patient care, which can improve health and job satisfaction.
AI could help improve healthcare in the United States. But fixing bias and inequality is needed for success. W. Nicholson Price II warns against rejecting AI just because it is not perfect. He calls refusing imperfect AI while ignoring problems in current healthcare the “nirvana fallacy.”
Medical practices should aim to use AI in a balanced way that improves care and efficiency while managing bias risks. Investing in better data, rules, clear processes, and training are important steps toward fair AI-driven healthcare.
Medical practice leaders, owners, and IT managers face the challenge of choosing, using, and checking AI tools carefully. Their decisions will affect how well AI helps provide fair and good care to all patients in the United States. Paying close attention to bias and ethics is needed not just for rules and safety but to keep patient trust and make AI work long term in healthcare.
AI can push human performance boundaries (e.g., early prediction of conditions), democratize specialist knowledge to broader providers, automate routine tasks like data management, and help manage patient care and resource allocation.
AI errors may cause patient injuries differently from human errors, affecting many patients if widespread. Errors in diagnosis, treatment recommendations, or resource allocation could harm patients, necessitating strict quality control.
Health data is often spread across fragmented systems, complicating aggregation, increasing error risk, limiting dataset comprehensiveness, and elevating costs for AI development, which impedes creation of effective healthcare AI solutions.
AI requires large datasets, leading to potential over-collection and misuse of sensitive data. Moreover, AI can infer private health details not explicitly disclosed, potentially violating patient consent and exposing information to unauthorized third parties.
AI may inherit biases from training data skewed towards certain populations or reflect systemic inequalities, leading to unequal treatment, such as under-treatment of some racial groups or resource allocation favoring profitable patients.
Oversight ensures safety and effectiveness, preventing patient harm from AI errors. Existing gaps exist for AI developed in-house or for non-medical functions; thus, health systems and professional bodies must enhance regulation where FDA oversight is absent.
Providers must adapt to new roles interpreting AI outputs, balancing reliance while maintaining clinical judgement. AI may either enhance personalized care or overwhelm with complex, opaque recommendations, requiring changes in education and training.
Government-led infrastructure improvements, setting EHR standards, direct investments in comprehensive datasets like All of Us and BioBank, and strong privacy safeguards can enhance data quality, availability, and trust for AI development.
Some specialties, like radiology, may become more automated, possibly diminishing human expertise and oversight ability over time, risking over-reliance on AI and decreased capacity for providers to detect AI errors or advance medical knowledge.
It refers to rejecting AI due to its imperfections by unrealistically comparing it to a perfect system, ignoring existing flaws in current healthcare. Avoiding AI due to imperfection risks perpetuating ongoing systemic problems rather than improving outcomes.